SEI INVESTMENTS CO - GLOBAL BLOOD THERAPEUTICS IN ownership

GLOBAL BLOOD THERAPEUTICS IN's ticker is GBT and the CUSIP is 37890U108. A total of 235 filers reported holding GLOBAL BLOOD THERAPEUTICS IN in Q3 2020. The put-call ratio across all filers is 0.88 and the average weighting 0.2%.

Quarter-by-quarter ownership
SEI INVESTMENTS CO ownership history of GLOBAL BLOOD THERAPEUTICS IN
ValueSharesWeighting
Q3 2021$650,000
-52.9%
25,690
-35.0%
0.00%
-66.7%
Q2 2021$1,381,000
+18.7%
39,535
+39.2%
0.00%0.0%
Q1 2021$1,163,000
-4.5%
28,406
+1.3%
0.00%0.0%
Q4 2020$1,218,000
-58.1%
28,039
-46.8%
0.00%
-62.5%
Q3 2020$2,908,000
-36.5%
52,728
-27.3%
0.01%
-42.9%
Q2 2020$4,576,000
+55.6%
72,479
+25.8%
0.01%
+27.3%
Q1 2020$2,940,000
+24.0%
57,605
+93.1%
0.01%
+57.1%
Q4 2019$2,371,000
+85.2%
29,827
+25.6%
0.01%
+75.0%
Q2 2019$1,280,000
+599.5%
23,751
+586.4%
0.00%
+300.0%
Q1 2019$183,000
-35.1%
3,460
-53.4%
0.00%0.0%
Q4 2018$282,0000.0%7,4300.0%0.00%0.0%
Q3 2018$282,000
-55.0%
7,430
-46.4%
0.00%
-50.0%
Q2 2018$626,000
+4.9%
13,850
+12.1%
0.00%0.0%
Q1 2018$597,00012,3510.00%
Other shareholders
GLOBAL BLOOD THERAPEUTICS IN shareholders Q3 2020
NameSharesValueWeighting ↓
GREAT POINT PARTNERS LLC 595,473$25,790,0004.19%
Grace Capital 131,549$5,697,0003.60%
Fernwood Investment Management, LLC 201,657$8,734,0003.44%
Fairmount Funds Management LLC 215,000$9,312,0003.33%
Arctis Global LLC 293,700$12,720,0002.74%
Perceptive Advisors 5,674,711$245,771,0002.64%
ArchPoint Investors 217,510$9,420,0002.61%
Alerce Investment Management, L.P. 126,270$5,469,0002.15%
Profit Investment Management, LLC 42,196$1,826,0001.17%
Affinity Asset Advisors, LLC 50,000$2,166,0001.15%
View complete list of GLOBAL BLOOD THERAPEUTICS IN shareholders